Business
KalVista Pharmaceuticals to Present EKTERLY® (sebetralstat) Data at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting
FRAMINGHAM, Mass. & SALISBURY, England, February 12, 2026--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the acceptance of three abstracts for presentation at the 2026 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting taking place in Philadelphia, Pennsylvania from February 27–March 2, 2026.
About this update from Kalvista Pharmaceuticals, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":474,"url":"https://media.zenfs.com/en/business-wire.com/3dff519cd67cffa49dd30df7aabd7cd2"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/76K1Vv.WE1gkTi5.GEqQpw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTk0ODtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/3dff519cd67cffa49dd30df7aabd7cd2","width":480,"height":474}},"lazy":false},{"type":"text","content":"FRAMINGHAM, Mass. & SALISBURY, England, February 12, 2026--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the acceptance of three abstracts for presentation at the 2026 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting taking place in Philadelphia, Pennsylvania from February 27–March 2, 2026.","length":355,"tagName":"p"},{"type":"text","content":"The following poster presentations will take place on Friday, February 27 from 2:45–3:45 pm ET in the Convention Center, Level 2, Hall E:","length":137,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Response Drivers in Sebetralstat Placebo-controlled Clinical Trials: Jonathan Bernstein, Emel Aygören-Pürsün, Danny Cohn, Henriette Farkas, William Lumry, Andrea Zanichelli, James Hao, Matthew Iverson, Michael Smith, Paul Audhya, Erik Hansen, Nathan Teuscher, Marc Riedl.","length":271,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"On-demand Treatment Patterns of Hereditary Angioedema Attacks with Sebetralstat in the KONFIDENT-S Study: Marc Riedl, Emel Aygören-Pürsün, Jonathan Bernstein, Danny Cohn, William Lumry, Michael Manning, Raffi Tachdjian, Daniel Soteres, Andrea Zanichelli, James Hao, Michael Smith, Paul Audhya, Henriette Farkas.","length":311,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":582,"olType":false},{"type":"text","content":"The following investigator-initiated study late-breaking poster presentation will take place on Sunday, March 1 from 9:45–10:45 am ET in the Convention Center, Level 2, Hall E:","length":176,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Management of Attacks and Burden in Patents with Hereditary Angioedema: Results from the ECRINS Survey: Laurence Bouillet, Alexis Bocquet, Delphine Gobert, Stéphane Ga...